First Time Loading...

AC Immune SA
NASDAQ:ACIU

Watchlist Manager
AC Immune SA Logo
AC Immune SA
NASDAQ:ACIU
Watchlist
Price: 2.35 USD 2.62% Market Closed
Updated: Apr 28, 2024

AC Immune SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AC Immune SA
Revenue Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
AC Immune SA
NASDAQ:ACIU
Revenue
CHf14.8m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$371.2m
CAGR 3-Years
709%
CAGR 5-Years
160%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf157.6m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%
Idorsia Ltd
SIX:IDIA
Revenue
CHf97.1m
CAGR 3-Years
60%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Revenue
CHf33.6m
CAGR 3-Years
103%
CAGR 5-Years
116%
CAGR 10-Years
N/A

See Also

What is AC Immune SA's Revenue?
Revenue
14.8m CHF

Based on the financial report for Dec 31, 2023, AC Immune SA's Revenue amounts to 14.8m CHF.

What is AC Immune SA's Revenue growth rate?
Revenue CAGR 5Y
16%

Over the last year, the Revenue growth was 280%. The average annual Revenue growth rates for AC Immune SA have been -1% over the past three years , 16% over the past five years .